1h Free Analyst Time
The oncology drugs market is forecasted to grow by USD 215.9 billion during 2024-2029, accelerating at a CAGR of 13.4% during the forecast period. The report on the oncology drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of cancer globally, need for cost-cutting in drug discovery and development, and rising initiatives by government and various non-profit organizations to spread awareness regarding cancer prevention.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
The oncology drugs market is segmented as below:
By Therapy
- Targeted therapy
- Immunotherapy and hormonal therapy
- Chemotherapy
By Distribution Channel
- Offline
- Online
By Form Factor
- Solid
- Liquid
- Injectable
By Indication
- Lung cancer
- Colorectal cancer
- Stomach cancer
- Others
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the oncology drugs market covers the following areas:
- Oncology Drugs Market sizing
- Oncology Drugs Market forecast
- Oncology Drugs Market industry analysis
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Analysis
3 Market Landscape
4 Market Sizing
5 Historic Market Size
6 Qualitative Analysis
7 Five Forces Analysis
8 Market Segmentation by Therapy
9 Market Segmentation by Distribution Channel
10 Market Segmentation by Form Factor
11 Market Segmentation by Indication
12 Customer Landscape
13 Geographic Landscape
14 Drivers, Challenges, and Opportunity/Restraints
15 Competitive Landscape
16 Competitive Analysis
17 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global oncology drugs market: AbbVie Inc., Amgen Inc., Apikos Pharma, Arlak Biotech Pvt. Ltd., Aspen Pharmacare Holdings Ltd., Astellas Pharma Inc., AstraZeneca Plc, Athenex Inc., Bayer AG, Bristol Myers Squibb Co., Eli Lilly and Co., F. Hoffmann La Roche Ltd., GlaxoSmithKline Plc, Johnson and Johnson Services Inc., Kremedine Health Pvt Ltd., Merck and Co. Inc., Novartis AG, Pfizer Inc., Sanofi SA, and Takeda Pharmaceutical Co. Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is rising adoption of immunotherapy."
According to the report, one of the major drivers for this market is the increasing prevalence of cancer globally.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Amgen Inc.
- Apikos Pharma
- Arlak Biotech Pvt. Ltd.
- Aspen Pharmacare Holdings Ltd.
- Astellas Pharma Inc.
- AstraZeneca Plc
- Athenex Inc.
- Bayer AG
- Bristol Myers Squibb Co.
- Eli Lilly and Co.
- F. Hoffmann La Roche Ltd.
- GlaxoSmithKline Plc
- Johnson and Johnson Services Inc.
- Kremedine Health Pvt Ltd.
- Merck and Co. Inc.
- Novartis AG
- Pfizer Inc.
- Sanofi SA
- Takeda Pharmaceutical Co. Ltd.
